Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.
about
Modulation of tumor necrosis factor by microbial pathogens.The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanismChronic viral infection and primary central nervous system malignancy.Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion.Cooperative inhibition of RIP1-mediated NF-κB signaling by cytomegalovirus-encoded deubiquitinase and inactive homolog of cellular ribonucleotide reductase large subunit.The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages.Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everythingThe Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteinsAblation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infectionEpstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1The human cytomegalovirus UL26 protein antagonizes NF-κB activation.Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of doseThe latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression.Suppression of RIP3-dependent necroptosis by human cytomegalovirusRoles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence.Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS.Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirusInsights into the mechanisms of CMV-mediated interference with cellular apoptosis.Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.Cross-regulation between herpesviruses and the TNF superfamily membersReduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis.Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infectionTumour necrosis factor in infectious disease.The intimate relationship between human cytomegalovirus and the dendritic cell lineage.Human cytomegalovirus suppresses Fas expression and function.Hepatitis C Virus Exploits Death Receptor 6-mediated Signaling Pathway to Facilitate Viral Propagation.Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infectionHuman cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling.The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling.Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages.Inhibition of tumor necrosis factor (TNF) signal transduction by the adenovirus group C RID complex involves downregulation of surface levels of TNF receptor 1.Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ.Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex.NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86.Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation.
P2860
Q21089629-A07031AD-7AB3-4391-A49A-E3FABA45D9E3Q24300688-F355BE80-9696-4454-8BA3-8273F72713FCQ30480064-8631A162-0951-4804-83D2-7621CEECABE5Q33644138-374E8066-0844-47BD-A0CB-4D52373BCB16Q33793216-2A3D9D88-05EB-41B9-9646-8A9881C97ECAQ33826894-3E7DC5F1-1556-4D48-95F2-6278814FED38Q34022257-0C90B085-EBFA-44DF-BAC1-5A4A91D095EEQ34291099-BBF695D8-A0FE-44A2-8D56-59CD1FD2ABC9Q34404551-046ACE1B-AFF9-4ECA-A1A9-D2B9081BF036Q34553626-985D2692-3160-48E2-BA66-8BB43CEEBC35Q34594875-AAF47A70-278D-40C6-A73D-3497C9BD3BFEQ34717215-5BF4E0A2-4E6D-4F02-95CE-0853201964C1Q35098707-C0AF77F8-9409-43A3-BD63-F6371FF80181Q35363103-0F70B861-6BCE-4F92-A1CF-F697F3EC9BB0Q35561085-FE927145-1AF7-4677-B3D3-4DFC116B8CA3Q35914507-35686766-44F1-4D97-8E7D-37FF680927F0Q36018410-66DDD2A4-4905-4A93-8D96-0AC53CDCB1B1Q36146446-610D4815-8974-4102-9B13-A082251967BFQ36365508-176BE9EF-F13C-4F69-9E1E-F63D64BB3867Q36509774-17F76DC5-1F4A-449A-AB0F-C4B05CFBB3EAQ36695499-E47A5EE9-3D04-462D-B440-0FB743282933Q37145244-4A5F3AF0-C76B-433B-A36B-BC7C46F1DD0CQ37299649-6107AB35-1300-40DA-889A-43D8EC2EC512Q37307520-53C5F185-10BF-42B3-9D86-21D6B5303E75Q37858352-A53082EC-5424-4EDF-98EE-BFD17DFFB381Q38042327-52C0F420-2BEE-4906-9114-3A266AEFC9F8Q38086506-C8F85ECF-665C-4C69-B5F8-F188ADED3EDDQ38242199-4150CDF6-8222-4E07-B969-65DACA141DB9Q38595352-E7EDC92C-DF9E-4C52-B672-F9C4C7F936ABQ38661559-9C0CFE23-D33D-40B4-987C-13551B9BC30BQ39167516-9B4F8914-65AF-4F4C-B3BF-BB53C82A3BD2Q39321145-EFB3F9C2-BE14-408C-B465-93087AB964EFQ39462585-B43B765E-7F6F-4E94-8375-7665C7761FC2Q39996413-BEE78686-EA67-47D9-9BBF-147295310073Q40274958-AFC16BB5-D1B8-4DF8-8DE2-F23358AD2604Q40303671-02A35915-9838-4D9F-891B-9668519E1D46Q40361594-BF556D12-033A-4E4B-8E67-0B1081D0EEF3Q42065930-8DDB3544-1407-4441-8CFF-53B4BBCBBE9BQ42424904-4363101E-86A2-4246-B158-94B5FACA7BE6
P2860
Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-alpha) signaling by targeting the 55-kilodalton TNF-alpha receptor.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Human cytomegalovirus infectio ...... kilodalton TNF-alpha receptor.
@en
Human cytomegalovirus infection inhibits tumor necrosis factor alpha
@nl
type
label
Human cytomegalovirus infectio ...... kilodalton TNF-alpha receptor.
@en
Human cytomegalovirus infection inhibits tumor necrosis factor alpha
@nl
prefLabel
Human cytomegalovirus infectio ...... kilodalton TNF-alpha receptor.
@en
Human cytomegalovirus infection inhibits tumor necrosis factor alpha
@nl
P2860
P1433
P1476
Human cytomegalovirus infectio ...... -kilodalton TNF-alpha receptor
@en
P2093
J H Sinclair
P2860
P304
P356
10.1128/JVI.77.12.7007-7016.2003
P407
P577
2003-06-01T00:00:00Z